US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.

Soft dendritic particles (SDPs) can be infused with chemotherapy drugs and embedded in a gel that can be applied to tumors for sustained medication release. Credit: CU Boulder ...